TipRanks on MSN

Revolution Medicines advances daraxonrasib into phase 3 pancreatic cancer trial, extending long-term upside potential

Revolution Medicines, Inc. ($RVMD) announced an update on their ongoing clinical study. Study Overview Revolution Medicines, Inc. is running a ...
GamesIndustry.biz

Our pick of the best GamesIndustry.biz features of 2025 | Year in Review

Permit us to toot our own horn for a brief moment. GamesIndustry.biz put out an incredible range of features in 2025, and ...